RESUMEN
As the coronavirus epidemic continues, a host of new cutaneous complications is seen on the faces of frontline healthcare workers wearing personal protective equipment on a daily basis. To minimize the risk of COVID-19 infection, healthcare workers wear tight-fitting masks that lead to an excessive amount of pressure on the facial skin. Mechanical pressure, mask materials, and perspiration can all lead to various types of cutaneous lesions such as indentations of the face, skin tears, post-inflammatory hyperpigmentation, ulceration, crusting, erythema, and infection. The objective of this article is to provide effective and straightforward recommendations to those health care providers using facial masks in order to prevent skin-related complications. J Drugs Dermatol. 2020;19(9):858-864. doi:10.36849/JDD.2020.5259.
Asunto(s)
Infecciones por Coronavirus/prevención & control , Dermatosis Facial/etiología , Traumatismos Faciales/etiología , Máscaras/efectos adversos , Pandemias/prevención & control , Equipo de Protección Personal/efectos adversos , Neumonía Viral/prevención & control , COVID-19 , Infecciones por Coronavirus/epidemiología , Eritema/etiología , Eritema/fisiopatología , Exantema/etiología , Exantema/fisiopatología , Dermatosis Facial/fisiopatología , Traumatismos Faciales/epidemiología , Traumatismos Faciales/fisiopatología , Femenino , Salud Global , Personal de Salud/estadística & datos numéricos , Humanos , Masculino , Exposición Profesional/prevención & control , Salud Laboral , Pandemias/estadística & datos numéricos , Neumonía Viral/epidemiología , Medición de RiesgoRESUMEN
Previously, we have reported that the N-methyl-D-aspartate (NMDA) receptor antagonist-benzodiazepine veterinary anesthetic combination, zoletil, produced reward and reinforcement, but only in rats repeatedly pretreated with the drug and not in drug-naïve rats. Therefore, we hypothesized that previous drug exposure plays an important role in the abuse of zoletil. In the present study, we examined whether pre-exposure to related substances, NMDA receptor antagonists (tiletamine, ketamine), and benzodiazepines (zolazepam, diazepam) predisposes animals to abuse zoletil. We examined whether animals repeatedly pretreated with tiletamine, ketamine, zolazepam, or diazepam, for 14 days, would show locomotor activation, place preference, and self-administration in response to zoletil. Place preference was observed in groups pretreated with either an NMDA receptor antagonist (ketamine) or a benzodiazepine (diazepam). However, locomotor activation and self-administration were only observed in rats pretreated with NMDA receptor antagonists (tiletamine and ketamine). These results show that pre-exposure to related substances might have induced neurobiological changes that consequently led to the expression of the rewarding and reinforcing effects of zoletil. This provides evidence that zoletil may be used as a substitute drug by abusers of NMDA receptor antagonists or benzodiazepines.